Autophagic action of new targeting agents in head and neck oncology
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autophagic action of new targeting agents in head and neck oncology
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 13, Issue 11, Pages 978-991
Publisher
Informa UK Limited
Online
2012-09-07
DOI
10.4161/cbt.21079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p65/RelA binds and activates thebeclin 1promoter
- (2014) Tamara Copetti et al. Autophagy
- Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD
- (2011) Yuria Saito et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Novel C-Terminal Hsp90 Inhibitor for Head and Neck Squamous Cell Cancer (HNSCC) with in vivo Efficacy and Improved Toxicity Profiles Compared with Standard Agents
- (2011) Stephanie M. Cohen et al. ANNALS OF SURGICAL ONCOLOGY
- Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
- (2011) Ying-Hong Shi et al. Autophagy
- Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck
- (2011) J M del Campo et al. BRITISH JOURNAL OF CANCER
- Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death
- (2011) Sandrine Eimer et al. CANCER BIOLOGY & THERAPY
- Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation
- (2011) Changyou Li et al. CANCER LETTERS
- Erlotinib-Mediated Inhibition of EGFR Signaling Induces Metabolic Oxidative Stress through NOX4
- (2011) K. P. Orcutt et al. CANCER RESEARCH
- Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells
- (2011) M. D. Bareford et al. CANCER RESEARCH
- Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
- (2011) V. Patel et al. CANCER RESEARCH
- Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
- (2011) A. Argiris et al. CLINICAL CANCER RESEARCH
- Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo
- (2011) K.-Y. Chang et al. CLINICAL CANCER RESEARCH
- Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer
- (2011) Ranee Mehra et al. DRUG RESISTANCE UPDATES
- Autophagy facilitates the Lapatinib resistance of HER2 positive breast cancer cells
- (2011) Suning Chen et al. MEDICAL HYPOTHESES
- Heat shock protein 90–mediated inactivation of nuclear factor-κB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells
- (2011) Qian Jiang et al. MOLECULAR BIOLOGY OF THE CELL
- MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis
- (2011) Y. Cheng et al. MOLECULAR CANCER THERAPEUTICS
- Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification
- (2011) J Tanizaki et al. ONCOGENE
- The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab–bevacizumab–irradiation combination on head and neck cancer xenografts
- (2011) Alexandre Bozec et al. ORAL ONCOLOGY
- Apicidin, a histone deaceylase inhibitor, induces both apoptosis and autophagy in human oral squamous carcinoma cells
- (2011) Mee-Young Ahn et al. ORAL ONCOLOGY
- EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells
- (2011) Weidong Han et al. PLoS One
- Autophagy contributes to resistance of tumor cells to ionizing radiation
- (2011) Hassan Chaachouay et al. RADIOTHERAPY AND ONCOLOGY
- Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
- (2010) Xinqun Li et al. Autophagy
- Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
- (2010) Yuan-Ling Liu et al. Autophagy
- Dasatinib induces autophagic cell death in human ovarian cancer
- (2010) Xiao-Feng Le et al. CANCER
- Acquired Cisplatin Resistance in Human Lung Adenocarcinoma Cells Is Associated with Enhanced Autophagy
- (2010) Jing-Hua Ren et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- The Epidermal Growth Factor Receptor Antibody Cetuximab Induces Autophagy in Cancer Cells by Downregulating HIF-1 and Bcl-2 and Activating the Beclin 1/hVps34 Complex
- (2010) X. Li et al. CANCER RESEARCH
- Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer
- (2010) S. Vergez et al. CLINICAL CANCER RESEARCH
- Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420
- (2010) Stephen K. Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes
- (2010) Lilian Amrein et al. LEUKEMIA RESEARCH
- Autophagy Induction with RAD001 Enhances Chemosensitivity and Radiosensitivity through Met Inhibition in Papillary Thyroid Cancer
- (2010) C.-I. Lin et al. MOLECULAR CANCER RESEARCH
- Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
- (2010) Margaret A. Park et al. MOLECULAR CANCER THERAPEUTICS
- Potential role of HDAC inhibitors in cancer therapy: Insights into oral squamous cell carcinoma
- (2010) A. Iglesias-Linares et al. ORAL ONCOLOGY
- Bcl-2 Regulates HIF-1α Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90
- (2010) Daniela Trisciuoglio et al. PLoS One
- Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma
- (2010) Chunrong Li et al. RADIOTHERAPY AND ONCOLOGY
- Autophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cells
- (2010) Yuqin Zhao et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
- (2009) C. H. Chung et al. ANNALS OF ONCOLOGY
- p62 at the Crossroads of Autophagy, Apoptosis, and Cancer
- (2009) Jorge Moscat et al. CELL
- Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer
- (2009) F. G. Pernas et al. CLINICAL CANCER RESEARCH
- Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases
- (2009) Gary Brandt et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
- (2009) Jean-Pascal H. Machiels et al. JOURNAL OF CLINICAL ONCOLOGY
- Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
- (2009) V. Milano et al. MOLECULAR CANCER THERAPEUTICS
- Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma
- (2009) O. Ekshyyan et al. MOLECULAR CANCER THERAPEUTICS
- Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase Activity
- (2008) Zhang Weihua et al. CANCER CELL
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- A Retroinhibition Approach Reveals a Tumor Cell-Autonomous Response to Rapamycin in Head and Neck Cancer
- (2008) P. Amornphimoltham et al. CANCER RESEARCH
- ERLOTINIB ACTIVATES MITOCHONDRIAL DEATH PATHWAYS RELATED TO THE PRODUCTION OF REACTIVE OXYGEN SPECIES IN THE HUMAN NON-SMALL CELL LUNG CANCER CELL LINE A549
- (2008) Xia Qian et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma
- (2008) Victor Y. Yazbeck et al. EXPERIMENTAL HEMATOLOGY
- Augmentation of Radiation Response by Panitumumab in Models of Upper Aerodigestive Tract Cancer
- (2008) Tim J. Kruser et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
- (2008) Y-M Chang et al. ONCOGENE
- Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients
- (2008) Hao-Hueng Chang et al. ORAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started